John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$275M |
| 2 |
Netflix
NFLX
|
+$254M |
| 3 |
Microsoft
MSFT
|
+$242M |
| 4 |
Qualcomm
QCOM
|
+$236M |
| 5 |
Starbucks
SBUX
|
+$232M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$236M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$221M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$191M |
| 4 |
McDonald's
MCD
|
+$183M |
| 5 |
Union Pacific
UNP
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.08% |
| 2 | Healthcare | 12.88% |
| 3 | Consumer Discretionary | 11.39% |
| 4 | Financials | 10.88% |
| 5 | Industrials | 10.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNAM
1026
DELISTED
Avidity Biosciences
RNAM
| $3.59M | 0.01% |
563,342
+48,521
| +9% | +$418K |
|
1027
Franklin Templeton
BEN
$17.6B
| $3.58M | 0.01% |
145,836
+111,436
| +324% | +$3.01M |
|
|
LPRO
1028
DELISTED
Open Lending Corp
LPRO
| $3.57M | 0.01% |
488,269
-115,980
| -19% | -$1.06M |
|
|
IBTX
1029
DELISTED
Independent Bank Group, Inc.
IBTX
| $3.57M | 0.01% |
90,321
+60,926
| +207% | +$2.49M |
|
1030
Ceco Environmental
CECO
$4.18B
| $3.56M | 0.01% |
223,093
-38,518
| -15% | -$527K |
|
1031
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$5.04B
| $3.56M | 0.01% |
49,180
+34,700
| +240% | +$2.68M |
|
1032
Seagate
STX
$180B
| $3.55M | 0.01% |
+53,781
| New | +$3.46M |
|
1033
Spok Holdings
SPOK
$222M
| $3.54M | 0.01% |
247,996
-93,317
| -27% | -$1.25M |
|
1034
World Acceptance Corp
WRLD
$887M
| $3.53M | 0.01% |
27,815
-18,029
| -39% | -$2.49M |
|
1035
Emergent Biosolutions
EBS
$266M
| $3.52M | 0.01% |
1,035,976
+334,051
| +48% | +$1.85M |
|
|
AAN
1036
DELISTED
The Aaron's Company Inc
AAN
| $3.51M | 0.01% |
334,952
+243,761
| +267% | +$3.11M |
|
1037
Xponential Fitness
XPOF
$216M
| $3.5M | 0.01% |
226,032
-2,654
| -1% | -$52.1K |
|
1038
Fate Therapeutics
FATE
$292M
| $3.5M | 0.01% |
1,651,272
-266,273
| -14% | -$882K |
|
1039
Omnicell
OMCL
$1.58B
| $3.5M | 0.01% |
77,710
+49,710
| +178% | +$3.01M |
|
1040
Hillman Solutions
HLMN
$1.61B
| $3.5M | 0.01% |
423,894
+98,494
| +30% | +$895K |
|
|
HTLF
1041
DELISTED
Heartland Financial USA, Inc.
HTLF
| $3.49M | 0.01% |
118,474
-1,780
| -1% | -$55.3K |
|
1042
New Horizon Aircraft
HOVR
$122M
| $3.48M | 0.01% |
330,000
| – | – |
|
|
INVX
1043
Innovex International
INVX
$2B
| $3.48M | 0.01% |
123,527
+101,417
| +459% | +$2.75M |
|
1044
Gran Tierra Energy
GTE
$352M
| $3.47M | 0.01% |
500,627
+277,702
| +125% | +$1.78M |
|
1045
MaxLinear
MXL
$5.69B
| $3.46M | 0.01% |
155,597
+16,193
| +12% | +$411K |
|
1046
Rapid7
RPD
$822M
| $3.45M | 0.01% |
75,300
+36,800
| +96% | +$1.7M |
|
1047
Galicia Financial Group
GGAL
$6.98B
| $3.44M | 0.01% |
263,858
+126,556
| +92% | +$2.06M |
|
|
SEM
1048
DELISTED
Select Medical
SEM
| $3.43M | 0.01% |
251,989
+192,597
| +324% | +$2.97M |
|
|
PRO
1049
DELISTED
PROS Holdings
PRO
| $3.42M | 0.01% |
98,708
-41,579
| -30% | -$1.44M |
|
1050
Chewy
CHWY
$10B
| $3.4M | 0.01% |
186,195
-2,115,496
| -92% | -$60.5M |
|
Similar funds
John Overdeck's Q3 2023 Portfolio in Review
As of Q3 2023, John Overdeck held 3,402 positions worth $37.2B, down 6.8% from $39.9B the previous quarter. Its ten largest holdings account for 7% of the portfolio.
John Overdeck withdrew a net $1.95B in Q3 2023, closing 472 positions and reducing 1,183 holdings. Its most notable exit was Etsy, an estimated $144M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, John Overdeck opened a new position in Eli Lilly worth $232M.
- John Overdeck's largest Q3 2023 buy was Eli Lilly: 432,734 shares worth $232M.
- John Overdeck added most to Advanced Micro Devices in Q3 2023, an estimated $275M increase.
- John Overdeck's biggest Q3 2023 reduction was Walmart Inc, cutting an estimated $236M.
- John Overdeck fully exited Etsy in Q3 2023, selling an estimated $144M.
- John Overdeck's ten largest holdings make up 7% of its $37.2B portfolio in Q3 2023.
- John Overdeck opened 430 new positions and closed 472 in Q3 2023.
- John Overdeck's portfolio value fell 6.8% quarter-over-quarter to $37.2B.
Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.